Molecular Imaging Market, by Product Type (Devices: Molecular Ultrasound Imaging, Positron Emission Tomography (PET), Single Photon Emission Computed Tomography (SPECT), Nuclear Magnetic Resonance (NMR) Spectrometer, and Hybrid Products {Positron Emission Tomography - Computed Tomography (PET-CT), Positron Emission Tomography - Magnetic Resonance (PET-MR), Single Photon Emission Computed Tomography - Computed Tomography (SPECT-CT), Single Photon Emission Computed Tomography - Magnetic Resonance (SPECT-MR)} and Software Platforms: On Premises Solutions and Cloud Based Solutions), by Application (Cardiovascular, Neurology, Oncology, Respiratory, Gastrointestinal, and Other Applications), by End Users (Hospitals, Diagnostic Imaging Centres, and Ambulatory Surgical Centres), and by Region (North America, Latin America, Europe, Asia Pacific, Middle East, and Africa) - Size, Share, Outlook, and Opportunity Analysis, 2022 - 2028
Molecular imaging is an area of medical imaging that focuses on imaging molecules of medical concern in living patients. It is integrated advanced imaging technology with molecular and cellular biology. It is safe, noninvasive, and painless procedure that is used to diagnose and manage a wide range of diseases such as cardiovascular, neurology, oncology, respiratory, and gastrointestinal. Molecular imaging is field of nuclear medicine. It includes small amount of radioactive materials (radiopharmaceuticals) to diagnose and treat disease. Moreover, molecular imaging helps to physician to disease management and improve personalize patient care.
Market Dynamics
Molecular imaging has become a part of the standard care for various types of cancer. The use of imaging techniques in early cancer detection, treatment response, and new therapy development is steadily growing and has significantly impacted the clinical management of cancer. Thus, increasing awareness of the early diagnosis is likely to boost the demand for diagnostic products such as positron emission tomography (PET), single-photon emission computed tomography (SPECT), positron emission tomography-computed tomography (PET-CT), single-photon emission computed tomography-computed tomography (SPECT-CT), etc. This, in turn, is expected to drive the global molecular imaging market growth. Moreover, a surge in the adoption of technologically advanced products is expected to drive the market growth. For instance, in June 2021, a leading provider of diagnostic imaging systems Canon Medical Systems USA Inc. a leading provider of diagnostic imaging systems, deep Learning Reconstruction (DLR) technology and Advanced intelligent Clear-IQ Engine (AiCE), both used in Cartesion Prime Digital PET/CT system, received 510(k) clearance from the U.S. Food and Drugs Administration (FDA). The Cartesion Prime with AiCE help clinicians consistently and routinely produce high-quality images.
Key features of the study:
This report provides an in-depth analysis of the global molecular imaging market, market size (US$ Mn), and compound annual growth rate (CAGR%) for the forecast period (2022-2028), considering 2021 as the base year
It elucidates potential revenue opportunities across different segments and explains attractive investment proposition matrices for this market
This study also provides key insights about market drivers, restraints, opportunities, new product launches or approval, market trends, regional outlook, and competitive strategies adopted by key players
It profiles key players in the global molecular imaging market based on the following parameters – company highlights, products portfolio, key highlights, financial performance, strategies.
Key companies covered as a part of this study include GE Healthcare, Bruker Corporation, Fujifilm Holdings Corp., Siemens Healthineers, Koninklijke Philips N.V., Canon Medical Systems Corporation, UNITED IMAGING HEALTHCARE CO., LTD., Mediso kft., Positron Corporation, ESAOTE S.P.A., Carestream Health, Mirada Medical Limited, and Hermes Medical Solutions
Insights from this report would allow marketers and the management authorities of the companies to make informed decisions regarding their future product launches, type up-gradation, market expansion, and marketing tactics
The global molecular imaging market report caters to various stakeholders in this industry including investors, suppliers, product manufacturers, distributors, new entrants, and financial analysts
Stakeholders would have ease in decision-making through various strategy matrices used in analyzing the global molecular imaging market.
Detailed Segmentation:
Global Molecular Imaging Market, By Product Type :
Devices
Molecular Ultrasound Imaging
Positron Emission Tomography (PET)
Single Photon Emission Computed Tomography (SPECT)
Nuclear Magnetic Resonance (NMR) Spectrometer
Hybrid Products
Positron Emission Tomography- Computed Tomography (PET-CT)
Positron Emission Tomography- Magnetic Resonance (PET-MR)
Single Photon Emission Computed Tomography - Computed Tomography (SPECT-CT)
Single Photon Emission Computed Tomography - Magnetic Resonance (SPECT-MR)
Software Platforms
On Premises Solutions
Cloud Based Solutions
Global Molecular Imaging Market, By Application:
Cardiovascular
Neurology
Oncology
Respiratory
Gastrointestinal
Other Applications
Global Molecular Imaging Market, By End User
Hospitals
Diagnostic Imaging Centers
Ambulatory Surgical Centers
Global Molecular Imaging Market, By Region:
North America
By Product Type
Devices
Molecular Ultrasound Imaging
Positron Emission Tomography (PET)
Single Photon Emission Computed Tomography (SPECT)
Nuclear Magnetic Resonance (NMR) Spectrometer
Hybrid Products
Positron Emission Tomography - Computed Tomography (PET-CT)
Positron Emission Tomography - Magnetic Resonance (PET-MR)
Single Photon Emission Computed Tomography - Computed Tomography (SPECT-CT)
Single Photon Emission Computed Tomography - Magnetic Resonance (SPECT-MR)
Software Platforms
On Premises Solutions
Cloud Based Solutions
By Application:
Cardiovascular
Neurology
Oncology
Respiratory
Gastrointestinal
Other Applications
By End User
Hospitals
Diagnostic Imaging Centers
Ambulatory Surgical Centers
By Country
U.S.
Canada
Latin America
By Product Type
Devices
Molecular Ultrasound Imaging
Positron Emission Tomography (PET)
Single Photon Emission Computed Tomography (SPECT)
Nuclear Magnetic Resonance (NMR) Spectrometer
Hybrid Products
Positron Emission Tomography - Computed Tomography (PET-CT)
Positron Emission Tomography - Magnetic Resonance (PET-MR)
Single Photon Emission Computed Tomography - Computed Tomography (SPECT-CT)
Single Photon Emission Computed Tomography - Magnetic Resonance (SPECT-MR)
Software Platforms
On Premises Solutions
Cloud Based Solutions
By Application:
Cardiovascular
Neurology
Oncology
Respiratory
Gastrointestinal
Other Applications
By End User
Hospitals
Diagnostic Imaging Centers
Ambulatory Surgical Centers
By Country
Brazil
Mexico
Argentina
Rest of Latin America
Europe
By Product Type
Devices
Molecular Ultrasound Imaging
Positron Emission Tomography (PET)
Single Photon Emission Computed Tomography (SPECT)
Nuclear Magnetic Resonance (NMR) Spectrometer
Hybrid Products
Positron Emission Tomography - Computed Tomography (PET-CT)
Positron Emission Tomography - Magnetic Resonance (PET-MR)
Single Photon Emission Computed Tomography - Computed Tomography (SPECT-CT)
Single Photon Emission Computed Tomography - Magnetic Resonance (SPECT-MR)
Software Platforms
On Premises Solutions
Cloud Based Solutions
By Application:
Cardiovascular
Neurology
Oncology
Respiratory
Gastrointestinal
Other Applications
By End User
Hospitals
Diagnostic Imaging Centers
Ambulatory Surgical Centers
By Country
Germany
U.K.
France
Italy
Spain
Russia
Rest of Europe
Asia Pacific
By Product Type
Devices
Molecular Ultrasound Imaging
Positron Emission Tomography (PET)
Single Photon Emission Computed Tomography (SPECT)
Nuclear Magnetic Resonance (NMR) Spectrometer
Hybrid Products
Positron Emission Tomography - Computed Tomography (PET-CT)
Positron Emission Tomography - Magnetic Resonance (PET-MR)
Single Photon Emission Computed Tomography - Computed Tomography (SPECT-CT)
Single Photon Emission Computed Tomography - Magnetic Resonance (SPECT-MR)
Software Platforms
On Premises Solutions
Cloud Based Solutions
By Application:
Cardiovascular
Neurology
Oncology
Respiratory
Gastrointestinal
Other Applications
By End User
Hospitals
Diagnostic Imaging Centers
Ambulatory Surgical Centers
By Country
China
India
Japan
Australia
South Korea
ASEAN
Rest of Asia Pacific
Middle East
By Product Type
Devices
Molecular Ultrasound Imaging
Positron Emission Tomography (PET)
Single Photon Emission Computed Tomography (SPECT)
Nuclear Magnetic Resonance (NMR) Spectrometer
Hybrid Products
Positron Emission Tomography - Computed Tomography (PET-CT)
Positron Emission Tomography - Magnetic Resonance (PET-MR)
Single Photon Emission Computed Tomography - Computed Tomography (SPECT-CT)
Single Photon Emission Computed Tomography - Magnetic Resonance (SPECT-MR)
Software Platforms
On Premises Solutions
Cloud Based Solutions
By Application:
Cardiovascular
Neurology
Oncology
Respiratory
Gastrointestinal
Other Applications
By End User
Hospitals
Diagnostic Imaging Centers
Ambulatory Surgical Centers
By Country
GCC
Israel
Rest of Middle East
Africa
By Product Type
Devices
Molecular Ultrasound Imaging
Positron Emission Tomography (PET)
Single Photon Emission Computed Tomography (SPECT)
Nuclear Magnetic Resonance (NMR) Spectrometer
Hybrid Products
Positron Emission Tomography - Computed Tomography (PET-CT)
Positron Emission Tomography - Magnetic Resonance (PET-MR)
Single Photon Emission Computed Tomography - Computed Tomography (SPECT-CT)
Single Photon Emission Computed Tomography - Magnetic Resonance (SPECT-MR)
Software Platforms
On Premises Solutions
Cloud Based Solutions
By Application:
Cardiovascular
Neurology
Oncology
Respiratory
Gastrointestinal
Other Applications
By End User
Hospitals
Diagnostic Imaging Centers
Ambulatory Surgical Centers
By Country/Region
South Africa
Central Africa
North Africa
Company Profiles
GE Healthcare*
Company Highlights
Products Portfolio
Key Highlights
Financial Performance
Strategies
Bruker Corporation
Fujifilm Holdings Corp.
Siemens Healthineers
Koninklijke Philips N.V.
Canon Medical Systems Corporation
UNITED IMAGING HEALTHCARE CO., LTD.
Mediso kft.
Positron Corporation
ESAOTE S.P.A.
Carestream Health
Mirada Medical Limited
Hermes Medical Solutions
“*” marked represents similar segmentation in other categories in the respective section.
Learn how to effectively navigate the market research process to help guide your organization on the journey to success.
Download eBook